Paper Review Records
全部论文审稿周期
28 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
33
天
73
天
Complex karyotype and non‐ BTK driver mutations associated with BTK inhibitor resistance in chronic lymphocytic leukaemia
作者
Kiyomi Mashima; Stacey M. Fernandes; Mariia Mikhaleva; Roberta Santos Azevedo; Stephen Martindale; Binu Kandathilparambil Sasi; Saurabh Yadav; Uday Aditya Sarkar; Rayan Fardoun; Xinhao Sun; Colin McNulty; Ava M. Kominski; Paige R. Fitzgerald; Ava Bidgoli; Paulina Predko; Samantha Shupe; John‐Hanson Machado; Aishath Naeem; Inhye E. Ahn; Matthew S. Davids; Jennifer R. Brown展开收起
作者单位
1. Department of Medical Oncology, CLL Center Dana‐Farber Cancer Institute Boston Massachusetts USA; 2. Department of Medicine Harvard Medical School Boston Massachusetts USA展开收起
128
天
CD20 antigen loss post‐venetoclax/anti‐ CD20 therapy in chronic lymphocytic leukaemia: Frequency, characteristics and potential therapeutic implications
作者
Tamasine Stewart; Sean McKeague; Divya Somasekharannair; Lei‐Shong Lau; Ashley Whitechurch; Joshua Casan; Neil Came; Kylie Baldwin; Vuong Nguyen; Ing Soo Tiong; Sean Harrop; Mary Ann Anderson; John F. Seymour; David Westerman; Philip A. Thompson; Kah Lok Chan展开收起
作者单位
1. Department of Pathology Peter MacCallum Cancer Centre Melbourne Victoria Australia; 2. Department of Clinical Haematology Peter MacCallum Cancer Centre and Royal Melbourne Hospital Melbourne Victoria Australia; 3. Department of Haematology Royal Brisbane and Women's Hospital Brisbane Queensland Australia; 4. Sir Peter MacCallum Department of Oncology The University of Melbourne Melbourne Victoria Australia; 5. School of Nursing and Midwifery La Trobe University Melbourne Victoria Australia展开收起
135
天
Spatial and transcriptomic analyses reveal the adverse prognostic impact of regulatory T cells in follicular lymphoma treated with rituximab–lenalidomide
作者
Camille Laurent; Marie Tosolini; Arnaud Guille; Bruno Tesson; Nathalie Van‐Acker; François‐Xavier Frenois; Andrea Belin‐Artola; Bastien Lesne; Pierre Brousset; BIDIFLY Consortium; Franck Morschhauser; Luc Xerri展开收起
作者单位
1. Laboratoire d'Excellence TOUCAN, Centre de Recherches en Cancérologie de Toulouse INSERM U1037, Institut Universitaire Cancer‐Oncopole, CHU Toulouse Toulouse France; 2. Institut Paoli‐Calmettes, CRCM and Aix‐Marseille University Marseille France; 3. LYSARC Pierre Bénite France; 4. Hopital Claude Huriez Lille France展开收起
175
天
A real‐time text‐based assessment tool for monitoring symptoms and quality of life for multiple myeloma patients: A feasibility study
作者
Victor Tellez; Anirvin Bommaraju; Jamie Cheung; Regina Swift; Jonathan Moore; Pierre Sayad; Frank Pezzullo; Aaron Gette; Alex Wright; Jon Hall; Randall Noval; Blake Morrison; James R. Berenson展开收起
作者单位
1. Berenson Cancer Center West Hollywood California USA; 2. Institute for Myeloma & Bone Cancer Research West Hollywood California USA; 3. mQOL San Jose California USA展开收起
166
天
Temporal trends in infectious risk among multiple myeloma patients treated with daratumumab: A meta‐analysis
作者
Alissa Visram; Hira Mian; James Lee; Aaron Jones; Gregory R. Pond; Doris Hansen; Surbhi Sidana; Luciano J. Costa展开收起
作者单位
1. Juravinski Cancer Centre Hamilton Health Sciences Hamilton Ontario Canada; 2. Department of Oncology, McMaster University Hamilton Ontario Canada; 3. ICES McMaster University Hamilton Ontario Canada; 4. Department of Health Research Methods, Evidence, and Impact McMaster University Hamilton Ontario Canada; 5. H. Lee Moffitt Cancer Centre & Research Institute Tampa Florida USA; 6. Division of Blood and Marrow Transplantation and Cellular Therapy Stanford University Stanford California USA; 7. Division of Hematology and Oncology, Department of Medicine University of Alabama at Birmingham Birmingham Alabama USA展开收起
FAQ
BRITISH JOURNAL OF HAEMATOLOGY审稿要多久?
截至2026-11-17,CrushSCI 收录了 BRITISH JOURNAL OF HAEMATOLOGY 的 28 篇完整审稿记录。最快一篇从收稿到录用用了 7 天(The speed of sequencing: Rapid molecular testing in acute myeloid leukaemia,2026-10-06 收稿,2026-10-13 录用),最慢一篇用了 225 天;平均 106.4 天,中位数 91.5 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
